David A Sullivan

USPTO Granted Patents = 18 (Patent Applications = 9)

CIPO Patents = 5 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 2.1

ph-index = 12

Forward Citations = 353(Granted Patents)

Location History:

Acton, MA (US) (1997 - 2000)
New York, NY (US) (2010)
Boston, MA (US) (2013 - 2023)

Company Filing History:

17 out of 126

The Schepens Eye Research Institute, Inc.

patents

10 out of 15,458

University of California

4. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2023

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11554048 - System and method for treating meibomian gland dysfunction (2023-01-17),

2. 9730978 - Compositions for treating dry eye disease (2017-08-15),

3. 9730865 - Application and uses of PRG4 and therapeutic modulation thereof (2017-08-15),

4. 9585936 - Method for therapeutic replenishment and enrichment of ocular surface lubrication (2017-03-07),

5. 9421241 - Therapeutic modulation of ocular surface lubrication (2016-08-23),

6. 9393285 - Compositions for treating dry eye disease (2016-07-19),

7. 9248161 - Method for therapeutic replenishment and enrichment of ocular surface lubrication (2016-02-02),

8. 9138457 - Therapeutic modulation of ocular surface lubrication (2015-09-22),

9. 8980840 - Therapeutic modulation of vaginal epithelium boundary lubrication (2015-03-17),

10. 8945604 - Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication (2015-02-03),

11. 8563028 - Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication (2013-10-22),

12. 8551467 - Replenishment and enrichment of ocular surface lubrication (2013-10-08),

13. 8506944 - Replenishment and enrichment of ocular surface lubrication (2013-08-13),

14. 7769676 - Exchange offer for securities (2010-08-03),

15. 6107289 - Ocular therapy in keratoconjunctivitis sicca using topically applied (2000-08-22),

Title: Innovations of David A. Sullivan

Introduction

David A. Sullivan is a notable inventor based in Acton, Massachusetts, with a remarkable portfolio of 18 patents. His work primarily focuses on advancements in medical treatments, particularly concerning gland dysfunctions.

Latest Patents

Among his latest patents, Sullivan has developed a system and method for treating meibomian gland dysfunction. This innovative approach involves reducing oxygen concentration in the environment of dysfunctional meibomian and sebaceous glands, thereby restoring their hypoxic status. The method includes restricting blood flow to these glands by contracting or closing surrounding blood vessels. Additionally, he has explored the application and uses of the protein PRG4, which includes its use as a surgical lubricant, treatment for post-surgical adhesions, and various other medical applications.

Career Highlights

Sullivan has made significant contributions to the field of medical research through his work at The Schepens Eye Research Institute and the University of California. His inventions have the potential to improve patient outcomes in various medical conditions.

Collaborations

Some of his notable coworkers include Benjamin D. Sullivan and Tannin Avery Schmidt, who have collaborated with him on various projects.

Conclusion

David A. Sullivan's innovative contributions to medical treatments highlight his expertise and dedication to improving healthcare solutions. His patents reflect a commitment to advancing medical technology and enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.